Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference
12 Enero 2023 - 7:00AM
Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome
engineering company, today announced that it will participate
virtually in B. Riley Securities’ 3rd Annual Oncology Conference.
B. Riley Securities’ 3rd Annual Oncology Conference –
Fireside ChatDate: Wednesday, January 18, 2023Time: 12:00
PM ET
A live webcast of the presentation will be available via the
Investors section of the Company's website at www.vorbio.com. An
archived replay of the webcast will also be available following the
conference.
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Vor Biopharma (NASDAQ:VOR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024